N-(3-((1-phenethyl-1H-pyrazolo[3,4-d]pyrimidin-4-ylamino)methyl)phenyl)benzamide

ID: ALA3128228

PubChem CID: 76329233

Max Phase: Preclinical

Molecular Formula: C27H24N6O

Molecular Weight: 448.53

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=C(Nc1cccc(CNc2ncnc3c2cnn3CCc2ccccc2)c1)c1ccccc1

Standard InChI:  InChI=1S/C27H24N6O/c34-27(22-11-5-2-6-12-22)32-23-13-7-10-21(16-23)17-28-25-24-18-31-33(26(24)30-19-29-25)15-14-20-8-3-1-4-9-20/h1-13,16,18-19H,14-15,17H2,(H,32,34)(H,28,29,30)

Standard InChI Key:  IKHOENLNOBJWRL-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 34 38  0  0  0  0  0  0  0  0999 V2000
    1.3399   -2.1791    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3388   -2.9987    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0468   -3.4076    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7565   -2.9982    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7537   -2.1755    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0450   -1.7703    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0466   -4.2248    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3388   -4.6333    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.3386   -5.4504    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6300   -5.8546    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.6294   -6.6710    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3376   -7.0806    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.0448   -5.8527    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0502   -6.6716    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8307   -6.9195    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.3077   -6.2537    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.8219   -5.5945    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0884   -7.6950    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8888   -7.8596    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1465   -8.6351    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6026   -9.2452    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8597  -10.0201    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6609  -10.1853    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2045   -9.5695    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9445   -8.7970    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4598   -1.7643    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.1691   -2.1702    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8752   -1.7589    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1721   -2.9874    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.5829   -2.1683    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2886   -1.7577    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2859   -0.9396    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5717   -0.5339    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8690   -0.9468    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  3  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 14  1  0
 13  9  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 13  1  0
 15 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 20  1  0
  5 26  1  0
 26 27  1  0
 27 28  1  0
 27 29  2  0
 28 30  2  0
 30 31  1  0
 31 32  2  0
 32 33  1  0
 33 34  2  0
 34 28  1  0
M  END

Associated Targets(Human)

TT (117 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HUVEC (11049 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RET Tclin Tyrosine-protein kinase receptor RET (6732 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KDR Tclin Vascular endothelial growth factor receptor 2 (20924 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 448.53Molecular Weight (Monoisotopic): 448.2012AlogP: 4.93#Rotatable Bonds: 8
Polar Surface Area: 84.73Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 3.62CX LogP: 4.76CX LogD: 4.76
Aromatic Rings: 5Heavy Atoms: 34QED Weighted: 0.35Np Likeness Score: -1.68

References

1. Sartini S, Coviello V, Bruno A, La Pietra V, Marinelli L, Simorini F, Taliani S, Salerno S, Marini AM, Fioravanti A, Orlandi P, Antonelli A, Da Settimo F, Novellino E, Bocci G, La Motta C..  (2014)  Structure-based optimization of tyrosine kinase inhibitor CLM3. Design, synthesis, functional evaluation, and molecular modeling studies.,  57  (4): [PMID:24447248] [10.1021/jm401358b]

Source